News & Updates
Filter by Specialty:
First-line niraparib maintenance regimen boosts PFS in advanced ovarian cancer
First-line maintenance therapy with niraparib at an individualized starting dose (ISD) improved progression-free survival (PFS) in patients with newly diagnosed advanced ovarian cancer, according to results of the phase III PRIME study presented at SGO 2022.
First-line niraparib maintenance regimen boosts PFS in advanced ovarian cancer
11 Apr 2022Greater adherence to Mediterranean diet reduces CVD burden
Even a slight increase in the level of adherence to the Mediterranean diet on a population basis results in significant decreases in new cardiovascular disease (CVD) cases and in better prognosis of patients with established CVD, according to two epidemiological studies.
Greater adherence to Mediterranean diet reduces CVD burden
11 Apr 2022Seladelpar safe, effective for primary biliary cholangitis
In patients with primary biliary cholangitis, the use of seladelpar, a selective peroxisome proliferator-activated receptor-delta agonist, safely improves biochemical markers of cholestasis and inflammation, reports a new study.
Seladelpar safe, effective for primary biliary cholangitis
10 Apr 2022Hepatitis B virus treatment rates still low among eligible patients
Administration rates of antiviral therapy remain low among treatment-eligible patients with chronic hepatitis B virus (CHB) and among CHB patients without human immunodeficiency virus (HIV), reveals a recent study.